Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥88 | ¥76 | ¥67 | ¥65 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Cost of Goods Sold | ¥44 | ¥38 | ¥35 | ¥34 |
| Gross Profit | ¥44 | ¥37 | ¥32 | ¥31 |
| % Margin | 49.9% | 49.4% | 48% | 47.8% |
| R&D Expenses | ¥0 | ¥9 | ¥10 | ¥10 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥38 | ¥21 | ¥20 | ¥20 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥3 | ¥3 | ¥2 |
| Operating Expenses | ¥38 | ¥33 | ¥34 | ¥33 |
| Operating Income | ¥6 | ¥4 | -¥1 | -¥1 |
| % Margin | 6.5% | 5.3% | -1.7% | -2.1% |
| Other Income/Exp. Net | ¥10 | ¥10 | ¥15 | ¥18 |
| Pre-Tax Income | ¥16 | ¥14 | ¥14 | ¥17 |
| Tax Expense | ¥4 | ¥3 | ¥3 | ¥3 |
| Net Income | ¥12 | ¥11 | ¥11 | ¥13 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS | 274.2 | 246.58 | 228.3 | 280.19 |
| % Growth | 11.2% | 8% | -18.5% | – |
| EPS Diluted | 274.2 | 246.58 | 228.3 | 280.19 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥5 | ¥4 | ¥4 | ¥4 |
| EBITDA | ¥20 | ¥19 | ¥18 | ¥20 |
| % Margin | 22.9% | 24.8% | 26.4% | 31% |